InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Schmidt Eric Thomas. Insider active across 3 companies, notably Allogene Therapeutics, Inc.. In total, 8 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €80k. History available since 24 May 2021. The latest transaction was disclosed on 8 June 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Schmidt Eric Thomas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,200 shares0Common StockSEC:0001610717-23-000132:0
558,094 shares0Common StockSEC:0001593968-23-000527:0
35,879 shares@ US$5.4737.7% of flowCommon StockSEC:0001737287-23-000024:0
5,200 shares0Common StockSEC:0001567619-22-013110:0
237,358 shares0Common StockSEC:0001214659-22-004371:0
11,469 shares@ US$7.63370.012% mcap26.5% of flowCommon StockSEC:0001214659-22-004084:0
3,617 shares0Common StockSEC:0001567619-21-012591:0
14,897 shares@ US$18.2245.8% of flowCommon StockSEC:0001214659-21-005926:0
8 of 8 declarations
About Schmidt Eric Thomas
Eric Thomas Schmidt is a director at Allogene Therapeutics, Inc. and Revolution Medicines, Inc.
